Clinical challenges in elderly asthma.

Yaşlı astımında klinik zorluklar.

Journal

Tuberkuloz ve toraks
ISSN: 0494-1373
Titre abrégé: Tuberk Toraks
Pays: Turkey
ID NLM: 0417364

Informations de publication

Date de publication:
Mar 2019
Historique:
entrez: 28 5 2019
pubmed: 28 5 2019
medline: 14 8 2019
Statut: ppublish

Résumé

Understanding the difference of elderly asthma is essential to provide better healthcare for this vulnerable population. The aim of this study was to evaluate the differences between young and elderly asthma patients. This real-life study was designed as a cross-sectional analysis. All data collected with structured web based asthma program. In sum, 373 (89.9%) young asthma (YA, age < 65) and 42 (10.1%) elderly asthma (EA, age < 65) patients followed at least one year and compared statistically. Cough is found higher in EA (p< 0.01) despite lower smoking rate in EA (p< 0.001). Allergic rhinitis and allergic conjunctivitis were more common in YA (p< 0.05, p< 0.01) which is consistent with higher allergy rate in YA (p< 0.05). On the other hand, diabetes and hypertension were determined significantly higher in EA (p< 0.01, p< 0.01). 52.4% of EA patients were found to have low diffusion capacity (DLCO < 80%). Although EA patients use combined therapies with inhaled corticosteroids and long acting beta agonists more than YA patients (p< 0.01), both emergency room visit (ERV) and hospitalization ratios are founded significantly higher in EA (p< 0.001, p< 0.001). EA patients were presented with cough in general. They possess an increased risk of hypertension, diabetes and low levels of diffusion capacity. ERV and hospitalization ratios have founded higher despite higher usage of combined therapies.

Identifiants

pubmed: 31130133
doi: 10.5578/tt.68041
doi:

Substances chimiques

Adrenal Cortex Hormones 0
Anti-Asthmatic Agents 0

Types de publication

Journal Article

Langues

eng

Pagination

31-38

Auteurs

Bilun Gemicioğlu (B)

Department of Chest Diseases, Faculty of Cerrahpasa Medicine, Istanbul University-Cerrahpasa, Istanbul, Turkey.

Benan Müsellim (B)

Department of Chest Diseases, Faculty of Cerrahpasa Medicine, Istanbul University-Cerrahpasa, Istanbul, Turkey.

Berk Değirmenci (B)

Faculty of Cerrahpasa Medicine, Istanbul University-Cerrahpasa, Istanbul, Turkey.

Esra Sarı (E)

Faculty of Cerrahpasa Medicine, Istanbul University-Cerrahpasa, Istanbul, Turkey.

Ayşe Firuze Özgökçe (AF)

Student, Faculty of Cerrahpasa Medicine, Istanbul University-Cerrahpasa, Istanbul, Turkey.

İpek Çalık (İ)

Student, Faculty of Cerrahpasa Medicine, Istanbul University-Cerrahpasa, Istanbul, Turkey.

Onur Merzifonlu (O)

Student, Faculty of Cerrahpasa Medicine, Istanbul University-Cerrahpasa, Istanbul, Turkey.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH